Skip to main content
. 2020 Nov 11;8(2):e001662. doi: 10.1136/jitc-2020-001662

Figure 4.

Figure 4

Progression-free survival for the stage III patients immunized with VRP-CEA. CEA, carcinoembryonic antigen; VRP, virus-like replicon particle.